Menu
GeneBe

4-122826956-G-A

Variant summary

Our verdict is Likely benign. Variant got -1 ACMG points: 0P and 1B. BP4

The ENST00000264498.9(FGF2):c.181G>A(p.Gly61Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000501 in 1,197,628 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 12/19 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).

Frequency

Genomes: not found (cov: 31)
Exomes 𝑓: 0.0000050 ( 0 hom. )

Consequence

FGF2
ENST00000264498.9 missense

Scores

2
2
12

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: 0.0530
Variant links:
Genes affected
FGF2 (HGNC:3676): (fibroblast growth factor 2) The protein encoded by this gene is a member of the fibroblast growth factor (FGF) family. FGF family members bind heparin and possess broad mitogenic and angiogenic activities. This protein has been implicated in diverse biological processes, such as limb and nervous system development, wound healing, and tumor growth. The mRNA for this gene contains multiple polyadenylation sites, and is alternatively translated from non-AUG (CUG) and AUG initiation codons, resulting in five different isoforms with distinct properties. The CUG-initiated isoforms are localized in the nucleus and are responsible for the intracrine effect, whereas, the AUG-initiated form is mostly cytosolic and is responsible for the paracrine and autocrine effects of this FGF. [provided by RefSeq, Jul 2008]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Likely_benign. Variant got -1 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.2723368).

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE UniProt
FGF2NM_001361665.2 linkuse as main transcriptc.-219G>A 5_prime_UTR_variant 1/3 ENST00000644866.2
FGF2NM_002006.6 linkuse as main transcriptc.181G>A p.Gly61Ser missense_variant 1/3

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Appris UniProt
FGF2ENST00000264498.9 linkuse as main transcriptc.181G>A p.Gly61Ser missense_variant 1/31 P09038-4
FGF2ENST00000644866.2 linkuse as main transcriptc.-219G>A 5_prime_UTR_variant 1/3 NM_001361665.2 P1P09038-2
FGF2ENST00000608478.1 linkuse as main transcriptc.-219G>A 5_prime_UTR_variant 1/31 P1P09038-2

Frequencies

GnomAD3 genomes
Cov.:
31
GnomAD4 exome
AF:
0.00000501
AC:
6
AN:
1197628
Hom.:
0
Cov.:
32
AF XY:
0.00000517
AC XY:
3
AN XY:
580656
show subpopulations
Gnomad4 AFR exome
AF:
0.00
Gnomad4 AMR exome
AF:
0.00
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.0000404
Gnomad4 FIN exome
AF:
0.0000353
Gnomad4 NFE exome
AF:
0.00000205
Gnomad4 OTH exome
AF:
0.0000207
GnomAD4 genome
Cov.:
31
Bravo
AF:
0.00000378

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not specified Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingAmbry GeneticsJan 22, 2024The c.181G>A (p.G61S) alteration is located in exon 1 (coding exon 1) of the FGF2 gene. This alteration results from a G to A substitution at nucleotide position 181, causing the glycine (G) at amino acid position 61 to be replaced by a serine (S). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.10
BayesDel_addAF
Benign
-0.10
T
BayesDel_noAF
Benign
-0.39
Cadd
Benign
10
Dann
Uncertain
0.98
Eigen
Benign
-0.74
Eigen_PC
Benign
-0.84
FATHMM_MKL
Benign
0.0069
N
LIST_S2
Benign
0.48
T;T
M_CAP
Pathogenic
0.64
D
MetaRNN
Benign
0.27
T;T
MetaSVM
Benign
-0.69
T
PrimateAI
Uncertain
0.72
T
PROVEAN
Benign
0.060
N;.
REVEL
Benign
0.27
Sift
Pathogenic
0.0
D;.
Sift4G
Benign
0.12
T;T
Polyphen
0.89
.;P
MutPred
0.30
Gain of phosphorylation at G61 (P = 2e-04);Gain of phosphorylation at G61 (P = 2e-04);
MVP
0.85
ClinPred
0.37
T
GERP RS
2.0
Varity_R
0.048
gMVP
0.087

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs1245576530; hg19: chr4-123748111; API